
16.42 Delayed Data As of Aug 05 | ![]() Today’s Change | 12.24 Today|||52-Week Range 28.06 | -29.65% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $2.7B |
ACADIA Pharmaceuticals, Inc. 12830 El Camino Real San Diego California 92130-3331 |
Stephen R. Davis | Chief Executive Officer & Director |
Srdjan R. Stankovic | President |
Brendan P. Teehan | Chief Operating Officer, EVP & Head-Commercial |
Mark C. Schneyer | Chief Financial Officer & Executive Vice President |
Bob Mischler | Senior VP-Strategy & Technology Operations |